We remain grateful for the work all health care workers and government officials are doing to keep our communities healthy and safe. Learn More
Improved diagnostic information for better patient management
Lantheus Holdings to Present at the Jefferies Virtual Healthcare Conference
Lantheus Holdings to Present at the UBS Virtual Global Healthcare Conference
Lantheus Holdings, Inc. Reports First Quarter 2020 Financial Results
We want to provide you with important information regarding our response to the COVID-19 pandemic.
(updated 4/15/2020)
Lantheus Holdings to Present at the Jefferies Virtual Healthcare Conference
Lantheus Holdings to Present at the UBS Virtual Global Healthcare Conference
Lantheus Holdings, Inc. Reports First Quarter 2020 Financial Results
At Lantheus, we develop, manufacture and commercialize essential diagnostic imaging agents and products that help healthcare professionals identify disease and improve patient treatment and care.
Setting the standard for diagnostic quality, safety and commitment with the leading echocardiography contrast agent in North America.
We are developing next generation imaging agents to enhance the accuracy, reliability and safety of diagnostic imaging.
Setting the standard for diagnostic quality, safety and commitment with the leading echocardiography contrast agent in North America.